1. What is the fee for the renewal of registration of a new drug?
2. What is the maximum period for which an Inspector can forbid a person in charge of premises from removing or dispensing therapeutic goods?
3. Who has the power to institute a prosecution for a contravention of any provision of the DRAP Act, 2012, and The Drugs Act, 1976?
4. If any difficulty arises in giving effect to any provision of the DRAP Act, who has the authority to remove the difficulty?
5. Which authority is responsible for issuing licences to manufacture drugs by way of repacking under section 18 of ordinance in a province?
6. According to the schedule in the Drugs (Specifications) Rules, what specifications should drugs bear that reference publications specified under sub-clause (ii) of clause (z) of Section 3?
7. Under Schedule-II, what is allowed in terms of distributing therapeutic goods as samples?
8. According to the Drug Licensing, Registering & Advertisement rules 1976, what type of information should advertisements to physicians and health-related professionals be consistent with?
9. What is the fee for submitting an appeal to the Appellate Board, as mentioned in the rules?
10. What is the penalty for a person who fails to provide information requested by the Authority?
11. What information should be included in the written contract between the contract giver and contract acceptor for contract manufacture?
12. For veterinary drugs, what is the source of specifications if they are not approved by the Registration Board?
13. What is the primary function of the Federal Drug Laboratory as stated in the rules?
14. Under what conditions is contract manufacture permissible?
15. What is the purpose of 'the Drugs (Federal Inspectors, Federal Drug Laboratory and Federal Government Analysts) Rules, 1976'?
16. What is the maximum quantity of a single drug that can be imported for personal use without exceeding the limit?
17. What is the procedure for appealing the suspension or cancellation of a license under Drugs Import & Export Rules 1976?
18. What is the meaning of "Reference Biotherapeutic Product (RBP)" under ScheduleI?
19. What condition must be met for a drug or substance to be advertised through press without reference to the Federal Government?
20. What is the penalty for a person who fails to provide information requested by the Authority?
21. What is the purpose of The Drug Regulatory Authority of Pakistan Act, 2012?
22. Which term refers to the set of operations that establish the relationship between values indicated by an instrument and known reference standards?
23. What is the purpose of Form 6?
24. What must be included in the labelling and promotion of a registered drug?
25. What is the purpose of the Central Research Fund mentioned in the Drugs Licensing, Registering & Advertising Rules 1976?
26. What is the role of the Appellate Board under The Drug Regulatory Authority of Pakistan Act, 2012?
27. What is the penalty for selling a drug in the finished form over and above the maximum retail price fixed by the Federal Government?
28. What is the term of office for members of the Registration Board?
29. What is the age requirement for the Chief Executive Officer (CEO) of the Authority?
30. What is the consequence of violating the conditions of a license to import drugs or the provisions of the Act?
31. What does the term "batch number (or lot number)" refer to?
32. What is the maximum duration of a licence issued under Drugs Licensing, Registering & Advertising rules 1976?
33. What is the condition under which printing of labeling for therapeutic goods is allowed under Schedule-II?
34. Under what condition can finished drugs be imported?
35. In what circumstances shall a drug not be deemed misbranded or adulterated?
36. Who is responsible for carrying out the audit of the Authority's accounts?
37. What does the term "Advertise" mean under Schedule-II?
38. What is the punishment for violating any prohibitions specified in Schedule-II of the DRAP Act?
39. What is the maximum duration for which the approval of an advertisement under sub-rule (1) is valid?
40. What is the penalty for a person who obstructs an Inspector in the exercise of any power conferred upon him under the Act?
41. What is the punishment for a person who exports, imports, manufactures for sale, or sells any spurious therapeutic good or any unregistered therapeutic good?
42. What is the short title of the rules that govern the Drugs Appellate Board?
43. What is the purpose of the Drug Regulatory Authority of Pakistan Fund?
44. What form should be used for applying for the grant or renewal of a licence to manufacture drugs?
45. How long do members, other than ex-officio members, of the Appellate Board hold office for initially?
46. In case of an appeal against the decision of the Registration Board rejecting an application for registration of a drug, what statement is required to be submitted?
47. What action should the Authority take in response to objections raised by the Auditor-General?
48. What does an Inspector require from a person during a search or seizure under Schedule-V?
49. Which court shall try an offense punishable under the DRAP Act, 2012, and The Drugs Act, 1976?
50. What is the purpose of the license to manufacture drugs for experimental purposes?
51. Which of the following offenses punishable under Schedule-III is non-cognizable?
52. What is the purpose of the Committee on Drugs Evaluation?
53. Which of the following is NOT included in the definition of "Biologicals" under Schedule-I?
54. What action should the Authority take in response to objections raised by the Auditor-General?
55. In case of inconsistency between the provisions of the DRAP Act and any other law, what takes precedence?
56. What is the purpose of an "airlock" in pharmaceutical manufacturing?
57. What is the Appellate Board's authority to call for the record of a case for review?
58. What is the purpose of the criteria regarding medical representatives?
59. What provision allows an exporter to recall issues already made from a batch of drugs that have been found to be in contravention of the Act or rules of 1976?
60. What is the definition of "promotion" for the purposes of Schedule G of 1976 Rules?
61. When can deviations be made from the information submitted during the registration of a drug?
62. What are "Medicated Cosmetics" under Schedule-I?
63. If any difficulty arises in giving effect to any provision of the DRAP Act, who has the authority to remove the difficulty?
64. How many members does the Policy Board consist of?
65. What is the purpose of Form 10 in the export of drugs?
66. What are "Medical Devices" under Schedule-I?
67. What type of containers are ophthalmic solutions and suspensions required to be contained in?
68. What does the term "Advertise" mean under Schedule-II?
69. What is the duration of a license to export drugs?
70. What labeling requirements apply to drugs manufactured for experimental purposes?
71. When a Federal Inspector is not competent to take action under Schedule-IV, what should he do?
72. Which of the following substances would NOT be considered a "Medicated Cosmetic"?
73. Under what circumstance can an exporter withdraw a batch of drugs from export after being informed by the licensing authority?
74. When does an Inspector need to divide a sample into three portoons instead of four?
75. What is the meaning of "Reference Biotherapeutic Product (RBP)" under ScheduleI?
76. In which situations may the Registration Board provisionally register a drug for a period of two years?
77. Which of the following is NOT included in the definition of "Biologicals" under Schedule-I?
78. What is the purpose of the Drug Regulatory Authority of Pakistan Fund?
79. In what type of premises should the manufacturing of drugs by way of basic or semi-basic manufacture take place?
80. Which type of research involves intervention, treatment, or medication programs using human subjects?
81. What is the punishment for a person who exports, imports, manufactures for sale, or sells any spurious therapeutic good or any unregistered therapeutic good?
82. Who shall not be liable for a contravention of Section 23 of the Drugs Act 1976?
83. What is the penalty for a subsequent offense under Clause (1) of Schedule-III?
84. For drugs other than those falling under specific categories, whose approval is required for the specifications?
85. What is the penalty for a person who obstructs an Inspector in the exercise of any power conferred upon him under the Act?
86. What substances are NOT included in the definition of "Drug" under Schedule-I?
87. What is the punishment for violating any prohibitions specified in Schedule-II of the DRAP Act?
88. Which power of the Inspector requires specific authorization by the Government?
89. In which circumstances may the Registration Board register a drug on its own motion?
90. Which of the following actions related to therapeutic goods is PROHIBITED under Schedule-II?
91. What is the tenure of the CEO's appointment, and how many times can it be extended?
92. Which Division is responsible for the evaluation, assessment, and registration of pharmaceutical drugs for human beings and animals?
93. The Central Research Fund fee collected by the Authority will be utilized for:
94. Who qualifies as a Federal Inspector according to these rules?
95. What is the maximum allowable retailer's discount for drugs?
96. What is the primary purpose of the Committee of Experts on Drug Research?
97. The Drugs Act, 1976 extends to which of the following areas?
98. The Authority may open its accounts with:
99. What are the types of licences to manufacture drugs under Drugs Licensing, Registering & Advertising rules 1976?
100. How often must records of quarterly production and disposal of a drug be supplied to the Chairman of the Registration Board?
